Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
about
Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and preventionTesting Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence RatesHIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation.Prevalence and determinants of hepatitis C virus infection among female drug injecting sex workers in Glasgow.Dry blood spot testing for hepatitis C in people who injected drugs: reaching the populations other tests cannot reach.Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users.Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population.Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations.Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies.Low incidence of hepatitis C virus among prisoners in Scotland.Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population.Intensity of human prion disease surveillance predicts observed disease incidence.Audit into blood-borne virus services in Her Majesty's Prison Service.Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection.Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993-2007.
P2860
Q27014761-DB08D4D9-4DCF-48FB-B55F-D382D0FC7059Q27485369-316D6B2B-4A6D-4865-93EE-B9ACDDF345F6Q30226766-E098A0B3-3E09-4402-A53C-2159D9C689E9Q33483115-4FCE2A5B-FBAA-48A4-93C1-BDF0D7BD37DCQ34764010-B6203C30-A80C-4EF8-B03D-B2F21671968DQ36580211-9A8E7676-D23B-4C5C-AA27-0273AC1BCA06Q38609090-DD3B7548-6C4E-4260-87C4-53C6AF437D1AQ39285745-6374DB1B-8D68-411A-A4AE-4BA40C87E475Q42642021-98928064-3104-407F-9DC0-0672D78F12AAQ42980113-553A8694-108B-4799-A8F9-8C9560EE113AQ42984463-2C4927EA-3658-4AFE-9280-416593416DF2Q42987991-459F041D-F049-4D56-8A92-FB49CF5EF4D3Q42990606-89C8D84C-157A-4CA1-9945-8B368C6F4494Q44748154-5D43DA6D-6DD3-4AAF-8649-511E28E04E23Q45395027-903412C3-7BDA-4BD5-8EAE-F3424DA40469Q45395726-C6C87379-8832-43A0-A6A8-6E0DFF83F151Q51126531-628ED8FB-5ACE-4FD4-B1D5-18E32E008A5AQ54256216-78B918CE-0DC2-4DB8-8341-D55D5E76FBBF
P2860
Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hepatitis C virus infection am ...... methods used to generate them.
@ast
Hepatitis C virus infection am ...... methods used to generate them.
@en
type
label
Hepatitis C virus infection am ...... methods used to generate them.
@ast
Hepatitis C virus infection am ...... methods used to generate them.
@en
prefLabel
Hepatitis C virus infection am ...... methods used to generate them.
@ast
Hepatitis C virus infection am ...... methods used to generate them.
@en
P2093
P2860
P1476
Hepatitis C virus infection am ...... methods used to generate them
@en
P2093
D J Goldberg
P G McIntyre
P Molyneaux
S J Hutchinson
S O Cameron
P2860
P304
P356
10.1017/S0950268806007035
P50
P577
2006-08-08T00:00:00Z